Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides
This study has been terminated.
Study NCT00400101 Information provided by Swiss Tropical & Public Health Institute
First Received on November 15, 2006. No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Falciparum Malaria
Additional conditions recognized in this trial
Malaria
Malaria, Falciparum
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Sponsors listed in this trial
Swiss Tropical & Public Health Institute
Back to top of Main Content